Detalhe da pesquisa
1.
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.
Antimicrob Agents Chemother
; 60(10): 5806-16, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27431214
2.
Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.
Antimicrob Agents Chemother
; 57(1): 26-36, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23027196
3.
Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment.
Pharmaceuticals (Basel)
; 14(3)2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668899
4.
Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.
Infect Immun
; 78(5): 1952-62, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194595
5.
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Antimicrob Agents Chemother
; 54(3): 1029-41, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20028819
6.
Stability of Porcine reproductive and respiratory syndrome virus at ambient temperatures.
J Vet Diagn Invest
; 22(2): 257-60, 2010 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20224088
7.
Complete Genome Sequences of 10 Phages Lytic against Multidrug-Resistant Pseudomonas aeruginosa.
Microbiol Resour Announc
; 9(29)2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675185
8.
Characterization of Acinetobacter baumannii Copper Resistance Reveals a Role in Virulence.
Front Microbiol
; 11: 16, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32117089
9.
Reply to "The Dual personality of iron chelators: growth inhibitors or promoters?".
Antimicrob Agents Chemother
; 57(5): 2434, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580580
10.
1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumannii.
ACS Med Chem Lett
; 8(1): 27-31, 2017 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105270
11.
1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial Pathogens.
ACS Infect Dis
; 3(1): 62-71, 2017 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764938
12.
Evaluation of Parameters for High Efficiency Transformation of Acinetobacter baumannii.
Sci Rep
; 6: 22110, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911658
13.
Laboratory Maintenance of Acinetobacter baumannii.
Curr Protoc Microbiol
; 35: 6G.1.1-6, 2014 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25367273
14.
An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization.
PLoS One
; 9(1): e85729, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24489668
15.
Genetic Manipulation of Acinetobacter baumannii.
Curr Protoc Microbiol
; 35: 6G.2.1-11, 2014 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25367274
16.
AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.
mBio
; 5(3): e01076-14, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24865555
17.
Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes.
FEMS Immunol Med Microbiol
; 64(3): 403-12, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22211672